Results 211 to 220 of about 14,131 (247)

[Papillary gingival hyperplasia].

open access: yesStomatoloski glasnik Srbije, 1973
Z, Pantelić   +2 more
openaire   +1 more source

Gingival Involvement in IgG4-Related Disease. [PDF]

open access: yesEur J Rheumatol
Qassimi SA   +4 more
europepmc   +1 more source

Propranolol-induced gingival hyperplasia with Nager syndrome: A rare adverse drug reaction.

open access: yesJ Adv Pharm Technol Res, 2016
Raheel SA   +4 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Diphenylhydantoin Gingival Hyperplasia

Archives of Pediatrics & Adolescent Medicine, 1969
DIPHENYLHYDANTOIN (Dilantin) sodium was synthesized in 1908 by Biltz1and introduced as an antiepileptic agent in 1938 by Merritt and Putnam.2Extensive subsequent use of this drug has confirmed its efficacy in controlling epileptic seizures, particularly major motor (grand mal) convulsions.
H L, Livingston, S, Livingston
openaire   +3 more sources

Nifedipine-Induced Gingival Hyperplasia

Drug Intelligence & Clinical Pharmacy, 1986
Gingival hyperplasia, a condition characterized by increased amounts of gingival connective tissue, has most commonly been observed in patients receiving phenytoin, but has also been noted in patients receiving cyclosporine and, as in this case report, nifedipine.
A A, Shaftic   +3 more
openaire   +2 more sources

Focal gingival hyperplasia in a horse

Journal of the American Veterinary Medical Association, 1993
A diagnosis of gingival hyperplasia in a 22-year-old Quarter Horse gelding was confirmed by histologic examination. Clinical signs included difficulty eating hay, and a large, intraoral soft tissue mass measuring 13 x 8 x 4.5 cm. The mass was located in the mucosa on the lingual aspect of the caudal left portion of the mandible, ventral to the base of ...
L H, Handy   +3 more
openaire   +2 more sources

Incidence of diphenylhydantoin gingival hyperplasia

Oral Surgery, Oral Medicine, Oral Pathology, 1972
Abstract The incidence of diphenylhydantoin gingival hyperplasia was studied in 173 hospitalized patients who were mainly middle aged and older. The incidence in this series was found to be 53.2 per cent; it was related to the degree of the patients' oral hygiene, while the age, sex, daily dosage of diphenylhydantoin medication, and duration of ...
A P, Angelopoulos, P W, Goaz
openaire   +2 more sources

[Gingival hyperplasia].

Medizinische Monatsschrift fur Pharmazeuten, 2010
Gingival hyperplasia is a typical adverse reaction of certain drugs (phenytoin, calcium antagonists and cyclosporine). Also oral contraceptives and presumably hormone replacement therapy may rarely lead to gingival hyperplasia. By differential diagnosis a paraneoplastic syndrome has to be taken into account.
Christiane, De Rop   +2 more
openaire   +1 more source

Home - About - Disclaimer - Privacy